| Role of the renin angiotensin system in diabetic nephropathy. | |
| | |
MedLine Citation:
|
PMID: 21537441 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Diabetic nephropathy has been the cause of lot of morbidity and mortality in the diabetic population. The renin angiotensin system (RAS) is considered to be involved in most of the pathological processes that result in diabetic nephropathy. This system has various subsystems which contribute to the disease pathology. One of these involves angiotensin II (Ang II) which shows increased activity during diabetic nephropathy. This causes hypertrophy of various renal cells and has a pressor effect on arteriolar smooth muscle resulting in increased vascular pressure. Ang II also induces inflammation, apoptosis, cell growth, migration and differentiation. Monocyte chemoattractant protein-1 production responsible for renal fibrosis is also regulated by RAS. Polymorphism of angiotensin converting enzyme (ACE) and Angiotensinogen has been shown to have effects on RAS. Available treatment modalities have proven effective in controlling the progression of nephropathy. Various drugs (based on antagonism of RAS) are currently in the market and others are still under trial. Amongst the approved drugs, ACE inhibitors and angiotensin receptor blockers (ARBs) are widely used in clinical practice. ARBs are shown to be superior to ACE inhibitors in terms of reducing proteinuria but the combined role of ARBs with ACE inhibitors in diabetic nephropathy is under debate. |
| | |
Authors:
|
Tanuj Chawla; Deepika Sharma; Archana Singh |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: World journal of diabetes Volume: 1 ISSN: 1948-9358 ISO Abbreviation: World J Diabetes Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2011-05-03 Completed Date: 2011-07-14 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 101547524 Medline TA: World J Diabetes Country: China |
Other Details:
|
Languages: eng Pagination: 141-5 Citation Subset: - |
Affiliation:
|
Tanuj Chawla, Department of Pharmacology, Lady Hardinge Medical College and Associated Hospitals, New Delhi 110001, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Contribution of animal models to the research of the causes of diabetes.
Next Document: Role of bile acid sequestrants in the treatment of type 2 diabetes.